Lipomyelomeningocele

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:268835
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Lipomyelomeningocele (also known as lipomyelomeningocele or lipomeningomyelocele) is a form of occult spinal dysraphism, classified among closed neural tube defects. It is a congenital malformation in which a lipoma (fatty mass) is attached to the spinal cord and extends through a defect in the vertebral arches (spina bifida) into the subcutaneous tissue, often presenting as a visible lump in the lower back. Unlike open myelomeningocele, the spinal cord and its coverings remain covered by skin, which is why it is considered a "closed" defect. The condition primarily affects the nervous system and musculoskeletal system. The lipoma tethers the spinal cord, which can lead to progressive neurological deterioration as the child grows. Key clinical features include a subcutaneous fatty mass in the lumbosacral region, tethered cord syndrome, lower extremity weakness or asymmetry, foot deformities (such as clubfoot), bowel and bladder dysfunction (including urinary incontinence or retention), and sensory changes in the lower limbs. Cutaneous stigmata such as skin dimples, hemangiomas, or abnormal hair patches may also be present over the affected area. Symptoms may be present at birth or develop progressively during childhood as growth places traction on the tethered spinal cord. Diagnosis is typically made through clinical examination and confirmed with MRI of the spine, which reveals the lipoma-cord interface and the degree of tethering. Prenatal ultrasound may also detect the abnormality. Treatment is primarily surgical, involving neurosurgical untethering of the spinal cord and debulking of the lipoma to prevent or halt neurological deterioration. The timing and necessity of surgery remain subjects of clinical debate, particularly in asymptomatic patients. Some centers advocate prophylactic surgery to prevent future neurological decline, while others prefer close monitoring with intervention only when symptoms develop. Long-term follow-up is essential, as re-tethering can occur after surgery, and ongoing urological and orthopedic management may be needed.

Inheritance

Multifactorial

Caused by a mix of several genes and environmental factors

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Lipomyelomeningocele.

View clinical trials →

No actively recruiting trials found for Lipomyelomeningocele at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Lipomyelomeningocele community →

No specialists are currently listed for Lipomyelomeningocele.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Lipomyelomeningocele.

Search all travel grants →NORD Financial Assistance ↗

Community

Open LipomyelomeningoceleForum →

No community posts yet. Be the first to share your experience with Lipomyelomeningocele.

Start the conversation →

Latest news about Lipomyelomeningocele

No recent news articles for Lipomyelomeningocele.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Lipomyelomeningocele

What is Lipomyelomeningocele?

Lipomyelomeningocele (also known as lipomyelomeningocele or lipomeningomyelocele) is a form of occult spinal dysraphism, classified among closed neural tube defects. It is a congenital malformation in which a lipoma (fatty mass) is attached to the spinal cord and extends through a defect in the vertebral arches (spina bifida) into the subcutaneous tissue, often presenting as a visible lump in the lower back. Unlike open myelomeningocele, the spinal cord and its coverings remain covered by skin, which is why it is considered a "closed" defect. The condition primarily affects the nervous system

How is Lipomyelomeningocele inherited?

Lipomyelomeningocele follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Lipomyelomeningocele typically begin?

Typical onset of Lipomyelomeningocele is neonatal. Age of onset can vary across affected individuals.